International Journal of Pancreatology

, Volume 27, Issue 1, pp 21–27 | Cite as

Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency

  • A. B. HaaberEmail author
  • A. M. Rosenfalck
  • B. Hansen
  • J. Hilsted
  • S. Larsen
Original Article


Background. Calcium and vitamin D homeostasis seem to be abnormal in patients with exocrine pancreatic dysfunction resulting from cystic fibrosis. Only a few studies have evaluated and described bone mineral metabolism in patients with chronic pancreatitis and pancreatic insufficiency.

Methods. Thirty-two patients with chronic pancreatitis and residual exocrine pancreatic function (group 1) and 26 patients with pancreatic exocrine insufficiency (i.e., meal-stimulated intraduodenal lipase <10% of lowest normal range and steatorrhea) (group 2) were studied. Serum levels of total calcium, phosphate, 25 (OH)D, 1.25(OH)2D, alkaline phosphatase, and parathyroid hormone were measured. Bone mineral density (BMD), bone mineral content (BMC), lean body mass (LBM), and fat mass (FM) were measured using a dual-energy X-ray absorptiometry (DXA) scanner.

Results. Alcohol was a causative factor in 79% of the patients. Fifty-six percent in group 1 and 69% in group 2 had Z-scores of the BMD<−1. The mean Z-score was −1.16±1.29 in group 1 and −1.32±0.90 in group 2. The mean Z-score of the BMC was −1.02±1.17 vs −1.39±0.987. In both groups mean 25 (OH)D and mean 1.25(OH)2D were below reference range. Plasma concentrations of albumin-corrected calcium, alkaline phosphatase, and parathyroid hormone were in the upper range of the reference range. Mean Z-scores of LBM were −0.69±1.34 in group 1 vs −1.01±1.12 in group 2 and Z-scores of FM were −0.27±1.70 in group 1 vs −0.95±1.01 in group 2 (p<0.05).

Conclusion. Patients with chronic pancreatitis, in particular patients with advanced disease and steatorrhea, are at risk of developing singificant bone loss. Despite normal body mass index the patients are characterized by loss of lean body mass and fat mass. The present study shows that these patients have decreased serum levels of vitamin D metabolites and low bone mass.

Key Words

Chronic pancreatitis pancreatic insufficiency bone mineral density body composition vitamin D lean body mass fat mass osteoporosis osteopenia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    DiMagno EP, Layer P, Clain JE. Chronic pancreatitis, in The Pancreas: Biology, pathobiology, and disease, Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. Raven Press, New York, 1993; pp. 665–706.Google Scholar
  2. 2.
    Dutta SK, Bustin MP, Russel RM, Costa BS. Deficiency of fat-soluble vitamins in treated patients with pancreatic insufficiency. Ann of Intern Med 1982; 97: 549–552.Google Scholar
  3. 3.
    Evans WB, Wollaeger EE. Incidence and severity of nutritional deficiency states in chronic exocrine pancreatic insufficiency: comparison with non-topical sprue. Am J Dig Dis. 1966; 11: 594–606.PubMedCrossRefGoogle Scholar
  4. 4.
    Mazess RB, Burden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for total and regional bone-mineral and soft tissue composition. Am J Clin Nutr 1990; 51: 1106–1112.PubMedGoogle Scholar
  5. 5.
    Rosenfalck AM, Almdal T, Hilsted J. Body composition in normal subjects: relation to lipid and glucose variables. Int J Obes 1996; 20: 1006–1013.Google Scholar
  6. 6.
    Morán CE, Sosa EG, Martinez SM, Geldern P, Messina D, Russo A, Boerr L, Bai JC. Bone mineral density in patients with pancreas insufficiens and steatorrhea. Am J Gastroenterol 1997; 92: 867–871.PubMedGoogle Scholar
  7. 7.
    Tjellesen L, Nielsen PK, Staun M. Body composition by dual-energy X-ray absorptiometry in patients with Crohn’s disease. Scand J Gastroenterol 1998; 33: 956–960.PubMedCrossRefGoogle Scholar
  8. 8.
    Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 417–422.PubMedCrossRefGoogle Scholar
  9. 9.
    Cummings SR, Black DM, Nevitt MC, Browner W, Cavley J, Ensrud K, et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993; 341: 72–75.PubMedCrossRefGoogle Scholar
  10. 10.
    Report of WHO Study Group. WHO technical reports series 843. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva 1994; WHO.Google Scholar
  11. 11.
    Bachrach K, Loutit CW, Hoss RB, Marcus R. Osteopenia in adults with cystic fibrosis. Am J Med 1994; 96: 27–34.PubMedCrossRefGoogle Scholar
  12. 12.
    Gibbens DT, Gilsanz V, Boechat MI, Dufer D, Carlson ME, Wang CI. Osteoporosis in cystic fibrosis. J Pediatr 1988; 113: 295–300.PubMedCrossRefGoogle Scholar
  13. 13.
    Hahn TJ, Squires AE, Halstead LR, et al. Reduced serum 25-Hydroxyvitamin D concentrations and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr 1979; 94: 38–42.PubMedCrossRefGoogle Scholar
  14. 14.
    Conzales-Calvin JL, Garcia-Sanchez A, Bellot V, et al. Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism. Alcohol & Alcoholism 1993; 571–579.Google Scholar
  15. 15.
    Diamond T, Stiel D, Lunzer M, Wilkman M, Poren S. Etanol reduces bone formation and may cause osteoporoses. Am J Med 1989; 86: 282–288.PubMedCrossRefGoogle Scholar
  16. 16.
    Royall D, Greenberg MD, Allard JP, Baker JP, Harrison JE, Jeejeebhoy KN. Critical assessment of body composition measurements in malnourished subjects with Crohn’s disease: the role of bioelectric impedance analysis. Am J Clin Nutr 1994; 59: 325–330.PubMedGoogle Scholar

Copyright information

© Humana Press Inc 2000

Authors and Affiliations

  • A. B. Haaber
    • 1
    Email author
  • A. M. Rosenfalck
    • 2
  • B. Hansen
    • 3
  • J. Hilsted
    • 2
  • S. Larsen
    • 1
  1. 1.Medical Department F, Glostrup HospitalUniversity of CopenhagenDenmark
  2. 2.Department of Endocrinology, Hvidovre HospitalUniversity of CopenhagenDenmark
  3. 3.Osteoporosis Research CentreUniversity of CopenhagenDenmark

Personalised recommendations